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Abstract
Purpose: To evaluate the effects of a referral process on diabetic retinopathy screening rates
among patients with Type 2 diabetes and formal documentation completion rates of these
screenings within a primary care setting.
Methods: A referral process for patient referral to an ophthalmologist for annual diabetic
retinopathy screening was instituted for a 4-week period within a Norton Community Medical
Associates (NCMA) primary care location for Type 2 diabetes patients. Charts of 30 patients
pre-intervention were compared with the charts of 30 patients seen during the intervention phase
of the study to evaluate the effects of the referral intervention. Demographic data, including age,
race, gender, and type of insurance, along with clinical data, including most recent Hgb A1C
level, were collected for data analysis comparison.
Results: There was no statistically significant difference between the demographic and clinical
data collected from the pre- and post-intervention groups. Additionally, the difference in referral
rates and formal documentation rates for the two groups was not statistically significant
(p>0.05).
Conclusion: A process improvement project using a brief referral intervention in a primary care
setting showed no effect. Further study into this type of intervention to increase diabetic
retinopathy screening rates in Type 2 diabetes patients and formal documentation completion
rates of these screenings may be more beneficial if performed over a longer study period with
evaluation of barriers preventing success at set time points during the study.
Keywords: Type 2 diabetes, diabetic retinopathy, dilated fundus examination, referral,
intervention, ophthalmology, documentation
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A Process Improvement Project to Increase Diabetic Retinopathy Screening Rates as
Evidenced by Formal Documentation
Background
Approximately 4.2 million Americans greater than age 65 years are affected by diabetic
retinopathy, a disease in which elevated blood glucose causes damage to the tiny blood vessels in
the retina of the eye (Weiss et al., 2015). Without effective healthcare interventions, the number
of people affected by diabetic retinopathy is expected to increase to three times that amount by
2050 (Zangalli et al., 2016). It is also estimated that, in 2004, more than $500 million was spent
on direct and indirect healthcare costs related to blindness caused by diabetic retinopathy and its
complications (Weiss et al., 2015). As the primary cause of new-onset blindness among
Americans aged 20 to 74 years (Weiss et al., 2015), this expected increase in the number of cases
of diabetic retinopathy will create a substantial and costly healthcare burden (Zangalli et al.,
2016).
Because diabetic retinopathy is asymptomatic in its early stages (Sheppler, Lambert,
Gardiner, Becker, & Mansberger, 2014) and because early detection of retinopathic changes by
annual dilated fundus examination is essential in the prevention of serious eye complications and
blindness (Walker, Schechter, Caban, & Basch, 2008), the American Diabetes Association
recommends that all individuals with Type 2 diabetes have a comprehensive dilated eye
examination soon after diagnosis (American Diabetes Association [ADA], 2013). Additionally,
according to the American Optometric Association’s “Evidence-based Clinical Practice
Guideline: Eye Care of the Patient with Diabetes Mellitus,” individuals with diabetes should
receive dilated eye examinations at least yearly and more frequently if they have changes in
vision or have diabetic retinopathy that is severe or progressing (American Optometric
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Association [AOA], 2014). However, compliance rates in obtaining annual dilated fundus
examinations remain low, with fewer than half of people with diabetes obtaining this annual
screening and with 50% of those that comply being screened too late for optimal treatment
(Weiss et al., 2015).
The issue further intensifies when considering that primary care providers are held at a
higher accountability for their patients receiving yearly screenings such as diabetic retinopathy
examinations. With yearly dilated fundus examinations now being part of one of the HEDIS
measurements, primary care providers risk changes in reimbursement when their diabetic
patients do not successfully complete this exam and/or when they cannot provide formal, written
documentation showing that their patients have had this service performed (Centers for Medicare
and Medicaid Services [CMS], 2015).
With the severity of the issue increasing in numbers and in costs, the question becomes,
“What are the most efficient healthcare interventions for promoting yearly diabetic eye exam
compliance in patients with Type 2 diabetes mellitus, and what is the best method of tracking
overall compliance rates?”
According to literature sources, interventions that contain an educational component that
emphasizes the importance of annual dilated fundus examinations along with a personal
component that helps patients overcome perceived barriers in getting the examinations may be
the most effective in improving yearly examination compliance (Brunisholz et al., 2014;
Sheppler et al., 2014; Walker et al., 2008; Weiss et al., 2015; & Zangalli et al., 2016). The
purpose of this paper is to evaluate the effects of a referral process on diabetic retinopathy
screening rates and formal documentation completion rates of these screenings among patients
with Type 2 diabetes in a primary care setting.
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Literature Review
A literature search was conducted to identify articles with interventions that focused on
the improvement of annual dilated fundus examination rates among people with diabetes. The
search terms were diabetes OR diabetic in the title AND intervention OR education in the title or
abstract AND eye OR fundus OR retinal OR vision in the title or abstract. The database used in
the search was PubMed.
Inclusion criteria for articles were: published between 2006 and 2016, written in English,
full-text available, peer-reviewed, and focused on human species. Exclusion criteria were:
studies that were not solely diabetes-focused, studies that concentrated only on Type 1 diabetes,
and studies that did not involve an intervention that explored annual dilated fundus examination
rates. A total of 103 articles were retrieved using the inclusion criteria. Five of these 103 articles
were chosen overall for this literature review once the exclusion criteria were applied.
Three of the reviewed studies were randomized controlled trials with one of these three
having a fairly large sample size of n=1,920. The overall levels of evidence among the studies
included four Level B studies as defined by the American Association of Critical-Care Nurses
(AACN) and one Level C study as defined by AACN (Melnyk & Fineout-Overholt, 2011). A
Level A meta-analysis of multiple controlled trials (Melnyk & Fineout-Overholt, 2011) that
specifically targeted interventions that improved annual dilated fundus compliance rates was not
found in the literature search.
All five of the reviewed literature studies suggest that interventions that contain an
educational component that emphasizes the importance of annual dilated fundus examinations
along with a personal component that helps patients overcome perceived barriers in getting the
examinations may be the most effective in improving annual dilated fundus examination
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compliance (Brunisholz et al., 2014, Sheppler et al., 2014, Walker et al., 2008, Weiss et al.,
2015, and Zangalli et al., 2016). One of the five reviewed studies suggested a possible
improvement in dilated fundus examination adherence with these two components present based
on survey results (Sheppler et al., 2014). Additionally, four of the five studies reviewed
suggested an improvement in dilated fundus examination compliance rates in the intervention
group versus the control group when both of these components were present. Interventions in
these four studies included a behavioral activation intervention versus supportive therapy, an
education- and telephone-based intervention versus standard care, a telephone intervention
versus printed materials, and a diabetic self-management education intervention versus standard
care (Brunisholz et al., 2014, Walker et al., 2008, Weiss et al., 2015, and Zangalli et al., 2016).
Purpose
The overall purpose of this process improvement project was focused on increasing
diabetic retinopathy screening rates among patients diagnosed with Type 2 diabetes by
implementing a referral process in a primary care setting. More specifically, this project focused
on the following objectives:
a. Increase the number of referrals to ophthalmology for diabetic retinopathy
screenings in Type 2 diabetes patients.
b. Increase the number of diabetic retinopathy screenings that were formally
documented in the patient’s electronic medical record.
Methods
Design
This study was a process improvement project to improve diabetic retinopathy screening
rates and formal documentation rates among patients with Type 2 diabetes. The results from this
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study will serve as a pilot study for the feasibility and initial effects of the intervention. The
study was conducted in four phases as follows:
Phase 1: Prior to implementation of the intervention, a retrospective chart review was
performed to evaluate current practice for referrals to ophthalmology for diabetic retinopathy
screening and formal documentation of completion of these exams within the patient population
of the primary care practice that was utilized for the project.
Phase 2: The principal investigator (PI) educated the providers and supporting medical
staff participating in the study about the process for referring Type 2 diabetes patients for
diabetic retinopathy eye exams.
Phase 3: After receiving education, the providers and office staff were instructed to
follow the referral process for all patients that met the inclusion criteria. This phase was
conducted over a 4-week period.
Phase 4: A second chart review was conducted after the 4-week period to evaluate the
number of patients that were properly referred for a diabetic retinopathy eye exam and the
number of cases in which formal documentation of these screenings was received back from the
ophthalmologist’s office.
Study Population
Provider Group: All of the providers within the designated Norton Community Medical
Associates (NCMA) practice were invited to participate in the study. Only patient charts from
participating providers who signed informed consent forms were audited after the educational
intervention. Inclusion criteria for providers were licensed healthcare providers (physicians,
nurse practitioners, or physician assistants) employed by Norton Healthcare (NHC).
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Chart Review Group: Inclusion criteria for Phase 1 and 4 were medical records of
patients with a diagnosis of Type 2 diabetes (ICD-10 codes of E11-E11.9) whose ages were
between 18-70 years old. Exclusion criteria were medical records of patients whose age was
outside of the specified age range of 18-70 years, those who did not have a current diagnosis of
Type 2 diabetes, patients with Type 1 diabetes, and pregnant women.
Permission to Conduct Study
Permission to conduct the study was granted from the University of Kentucky (UK)
Institutional Review Board (IRB) and from the Norton Healthcare Office of Research
Administration (NHORA). As data collection from patient records was retrospective and deidentified, a waiver of informed consent was granted. All prescribing medical providers were
consented at a routine in-office staff meeting where they were given an informed consent form
and asked to participate in the study. Supporting medical staff members were also educated at
this time on their roles in the successfulness of the intervention.
Procedures
Phase 1: Needs Assessment. In order to conduct a needs assessment, a retrospective
chart review of 30 patient medical records was completed to assess the designated NCMA
office’s current diabetic retinopathy screening rates and the rates of formal documentation within
their Type 2 diabetes patients’ medical records. The medical records were randomly selected
from Type 2 patients seen in the practice for all appointment types between January 1, 2016 and
December 31, 2016 that fit the inclusion and exclusion criteria previously discussed as
characteristics of the chart review group. Charts for review were randomized by the IT
Department at Norton Healthcare and sent to the primary investigator in an Excel spreadsheet
with medical record numbers listed. The primary investigator assessed the medical records
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through the EPIC electronic medical record (EMR). This was done in a private room with no
other individuals present. Information including the number of referrals for dilated fundus
screening performed, the number of diabetic retinopathy screenings reported and/or documented,
and the number of patients in which formal documentation of screening was present in the EMR
was obtained. Additionally, information on the patients’ age, race, gender, pregnancy status, type
of insurance, and most recent Hgb A1C level was collected for data analysis comparison.
Phase 2: Educational Intervention and Referral Process. To begin the intervention
phase, the PI met with the NCMA providers and supporting medical staff to introduce the
referral process and to answer questions regarding the implementation process. Education
included the need for a referral protocol, the target patient population for the study, where to
enter ophthalmology referrals into EPIC, and the process for making the patients’ ophthalmology
appointments and faxing the patient documentation form at patient check-out.
The referral process for patients that met the inclusion criteria was as follows. When
patients came in for any appointment type and had a diagnosis of Type 2 diabetes in their
electronic medical record, the primary care provider was to interview the patient and review the
EMR to determine if the patient had completed their annual diabetic retinopathy screening by
dilated fundus exam within the past 12 months. This discussion between the patient and the
provider was to occur as part of the patient’s health maintenance assessment as per usual
practice.
If the patient stated that they had not had their annual screening, the primary care
provider was instructed to enter a referral into the system to a local ophthalmologist of patient
and/or provider choice. If the patient refused a referral, the provider was to enter a note in the
referral section to document the refusal. Any education that the provider felt compelled to share
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with the patient about the importance of the diabetic retinopathy exam should have taken place at
this time as well.
At check-out, the patient’s paperwork should have reflected the referral, alerting office
staff members that they needed to aid the patient in scheduling their ophthalmology appointment.
This assistance in scheduling the appointment for the patient was designed as part of the
intervention as a personal component to help overcome any patient-perceived barriers to the
screening, for this was a key factor in increasing screening rates as seen in the review of the
literature.
When making the appointment, the formal documentation form designed for this study
was to be faxed to the referred ophthalmologist with instructions to fax it back upon completion
of the diabetic retinopathy eye exam (see Appendix 1). If check-out paperwork stated the
patient’s refusal for a referral, office staff was instructed to provide the formal documentation
form to the patient for when or if they made their own ophthalmology appointment. Once the
form was completed and faxed back to the NCMA office from the ophthalmology office showing
completion of the diabetic retinopathy eye exam, NCMA office staff was educated to scan it into
the system as a permanent part of the patient’s medical record.
Phase 3: Implementation Phase. The implementation phase of the study lasted for 4
weeks. During this phase, consenting providers conducted visits with their normal patient
population and were to use the referral process on all Type 2 diabetes patients that met the
inclusion criteria. Providers and staff were to follow all of the steps of the referral process
described in Phase 2 during this time. The PI had no contact with patients during this phase, and
contact with consenting providers was limited to providers contacting the PI with questions they
had regarding the referral process.
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Phase 4: Chart Review after 4-week Implementation Phase. The PI conducted a
second chart review of the patient medical records from participating providers after the 4-week
implementation phase. This chart review was performed on Type 2 diabetes patients that were
seen during the implementation phase that fit the inclusion and exclusion criteria previously
discussed as characteristics of the chart review group. Thirty charts were randomly selected by
the IT Department at Norton Healthcare using the inclusion and exclusion criteria, and medical
record numbers were sent to the PI within an Excel spreadsheet. Charts were reviewed 4 weeks
after completion of the implementation phase as to allow time for completion of the scheduled
ophthalmology exams and attainment of the formal documentation forms from ophthalmology to
the primary care office. This chart review was conducted in a private room with no other
individuals present.
The 30 randomized charts of Type 2 diabetes patients seen for all appointment types
during the implementation phase were reviewed for information including the number of
referrals for dilated fundus screening performed, the number of diabetic retinopathy screenings
reported and/or documented, the number of patients in which a referral was indicated at the time
of their appointment, and the number of patients in which formal documentation of screening
was received back from ophthalmology. Additionally, information on the patients’ age, race,
gender, pregnancy status, type of insurance, and most recent Hgb A1C level was collected for
data analysis comparison to pre-intervention data.
Data Analysis
Descriptive statistics, including means, standard deviations, and frequencies, were used to
summarize the data for the pre- and post-intervention groups. Bivariate statistics, including the
two-sample t-test and chi-square test of association, were used to compare demographic
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characteristics between the two groups at each time. All data analysis was conducted using SPSS
Version 22. An alpha level of 0.05 was used to determine statistical significance.
Results
Within the NCMA, Mount Washington location, all 6 providers consented to participate
in the study. Patient medical records that fit the inclusion and exclusion criteria previously
discussed as characteristics of the chart review group were randomly selected by the IT
Department at Norton Healthcare to fulfill the PI’s request of a pre-intervention group and a
post-intervention group of 30 patients each. All 60 patient medical records that were reviewed
met the inclusion and exclusion requirements.
Bivariate statistics showed no statistically significant difference between the
demographic and clinical data collected from the pre- and post-intervention groups (see Table 1).
A two-sample t-test comparing age and most recent Hgb A1C and a chi-squared test of
association comparing gender, race, and type of insurance payor showed that there was no
statistically significant difference between the groups with a p-value >0.05 in all categories.
The pre-intervention group had a mean age of 57.8 years and a mean last Hgb A1C of
7.1. The group consisted of 40% males and 60% females with 96.7% being Caucasian. The postintervention had a mean age of 55.6 years and a mean last Hgb A1C of 7.7. The group consisted
of 36.7% males and 63.3% females with 93.3% being Caucasian.
After performing a chi-square test of association and obtaining a p-value >0.05, it was
determined that the difference in referral rates and formal documentation rates for the two groups
was not statistically significant (see Table 2). The pre-intervention indication of screening rate
could not be assessed since the needs assessment chart review consisted of a review of all Type 2
diabetes patient visits in the specified 12-month time period, and the diabetic retinopathy
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screening is an every 12-month intervention. However, the post-intervention indication for
screening rate could be assessed, and despite an indication for referral during the intervention
phase of 66.7%, the referral rate for the pre- and post-intervention groups was unchanged at
3.3%. Additionally, the formal documentation rate was less for the post-intervention group at
13.3% compared to the pre-intervention rate of 26.7%.
Discussion
The brief referral intervention used in this process improvement project within a single
primary care setting showed no effect. The two main objectives of the study were not met, as
referral rates for diabetic retinopathy screenings did not increase nor did formal documentation
completion rates of these screenings.
The decrease in the formal documentation rates in the post-intervention group versus the
pre-intervention group could likely be explained by the fact that the pre-intervention group’s rate
was evaluated over a 12-month period, whereas the post-intervention group was only evaluated
over a 1 to 2-month period, depending on when the post-intervention patients had their follow-up
appointment within the intervention phase. An evaluation of the post-intervention group over a
longer period of time to allow for more time for completion of diabetic retinopathy screenings
likely would have increased this percentage. This decrease might also be explained by an issue
with the form designed for this study not being properly routed to the ophthalmology office. An
evaluation of the check-out and referral procedures after the patient was referred was not
assessed but may have been useful.
The unchanged referral rate pre-intervention versus post-intervention might be explained
by the type of appointment the patient had scheduled, by time constraints inherent in providers’
busy schedules, and/or by expected and unexpected barriers that are often seen with change
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processes. This could have been the case, for instance, if a Type 2 diabetes patient was being
seen for a respiratory issue where the patient’s Type 2 diabetes was not the focus of the
appointment. In this case, the illness might have taken precedence over any thought or emphasis
on the diabetic retinopathy screening exam or even any diabetes treatment at all. Additionally, it
might have been the case that the provider seeing the patient for the appointment simply forgot to
refer, chose not to refer based on their personal knowledge of the patient, or ran out of time to
refer for various reasons.
Limitations
The biggest limitation in this study was time. The intervention phase of the study was
only 4 weeks long, and the post-intervention chart review was only performed on charts up to 4
weeks after completion of the intervention phase. An intervention phase limited to such a small
time window might have made it difficult for providers to remember to enact the change into
their normal work routine, which could explain the limited number of referrals made to
ophthalmology during the study. Additionally, a post-intervention chart review lasting only 4
weeks after completion of the intervention phase may have been an inadequate time frame for
patients to have their ophthalmology screenings performed, documentation of the screenings to
be returned from ophthalmology, and/or documentation uploaded into the patients’ electronic
medical records once returned. This could explain the decrease in formal documentation rates in
comparison to the pre-intervention group.
Another limitation of the study was an inability, mostly limited by time constraints, to
evaluate how closely the referral intervention process was followed. The PI did not have any
interaction with the providers or the staff during the intervention phase. As such, the providers
were not reminded to put in referrals for diabetic retinopathy screenings, and the staff was not
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reminded to fax the form designed for this study to the ophthalmologist office once a referral was
made. Additionally, the forms that were faxed to ophthalmology were not kept for further review
to evaluate if the process was correctly followed, and interviews about the process were not
performed for adherence or barrier to adherence evaluation. All of these factors could have
contributed to a lower than expected referral rate and formal documentation rate.
Additional limitations of this study included a small sample size and homogenous
demographics. Because this was a pilot study, only one primary care office seeing mostly
Caucasian patients was studied, and only 60 charts in total were reviewed between the preintervention and post-intervention groups. Related to these specific study limitations, the study
findings do not allow for application to the general population, but they do hold significance for
the particular primary care office studied.
Implications for Clinical Practice
Literature sources suggest that interventions that contain an educational component that
emphasizes the importance of annual dilated fundus examinations along with a personal
component that helps patients overcome perceived barriers in getting the examinations may be
the most effective in improving annual dilated fundus examination compliance (Sheppler et al.,
2014, Walker et al., 2008, Weiss et al., 2015, and Zangalli et al., 2016). Patients in the literature
studies were up to 2.5 times more likely to get their dilated retinopathy screenings when these
two components were present (Walker et al., 2008, Weiss et al., 2015, and Zangalli et al., 2016).
Nevertheless, this short-term pilot study in a primary care office showed no effect when an
intervention that contained these components was implemented. However, future studies that
include modifications to how this pilot study was implemented and evaluated may be beneficial
in order to determine the true value of the type of intervention used in this study.
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Further study performed over a longer study period with evaluation of barriers preventing
success at set time points during the study might be especially useful. Evaluation of referral
compliance when Type 2 diabetes patients are being seen specifically for diabetes follow-up
appointments instead of all appointment types may also uncover unexpected barriers to referral.
Additionally, a pre-designed educational handout, rather than varied verbal education, that
providers could give patients that they refer to ophthalmology might better fit the necessary
educational component uncovered in the literature review to increase screening compliance and
formal documentation rates. Furthermore, an evaluation over an extended study period of all of
the individuals that explicitly receive referrals during the intervention period versus just
evaluating a random sample may give more insight into the effectiveness of the referral process
on the receipt of formal documentation. And, allowing for a longer amount of time to assess
compliance in patients from the intervention group completing their annual dilated fundus
examination after they receive their referral may offer more insight into the true effect of the
referral intervention on formal documentation rates.
Conclusion
Annual dilated fundus examinations are the standard of care in the prevention of and
complications from diabetic retinopathy in patients with Type 2 diabetes (Walker, Schechter,
Caban, & Basch, 2008). Literature sources suggest that interventions that focus on education
related to diabetic retinopathy exam importance and that help patients overcome barriers to
exams may be the most successful at increasing compliance rates (Brunisholz et al., 2014;
Sheppler et al., 2014; Walker et al., 2008; Weiss et al., 2015; & Zangalli et al., 2016). A brief
referral intervention in a primary care setting that utilized these components showed no effect in
compliance or formal documentation evidencing compliance, but study limitations may have
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skewed the true capability of the intervention’s effect. Further study over a longer time period
with modifications made to this study’s intervention is suggested to evaluate the potential effect
of referral on dilated fundus exam compliance and formal documentation rates.
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Table 1. Demographic and Clinical Data Summary (N=60)

Pre-intervention (n=30)

Post-intervention (n=30)

p

Age, Mean (SD)

57.8 (9.3)

55.6 (11.3)

0.07

Last Hgb A1C, Mean (SD)

7.1 (1.4)

7.7 (1.9)

0.35

40%
60%

36.7%
63.3%

0.79

Race
White
African American
Asian
Other

96.7%
3.3%
0%
0%

93.3%
0%
3.3%
3.3%

0.39

Payor Type
Private Insurance
Medicaid/Medicare

63.3%
36.7%

46.7%
53.3%

0.19

Gender
Male
Female
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Table 2. Frequency of Study Indicators (N=60)

Pre-intervention (n=30)

Post-intervention (n=30)

p

Referral Written

3.3%

3.3%

1

Patient-reported Exam

43.3%

33.3%

0.43

Formal Documentation

26.7%

13.3%

0.20

Referral Indicated

Unable to assess

66.7%

N/A
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Appendix
Appendix 1: Diabetic Retinopathy Screening Form
DIABETES EYE EXAM REFERRAL AND COMMUNICATION FORM
PLEASE FAX THIS COMPLETED FORM TO THE REFERRING PRIMARY CARE PROVIDER
UPON COMPLETION OF THE PATIENT VISIT
To: Optometrist/Ophthalmologist
Name:

____________________________________________

Address: ____________________________________________
Phone:

____________________________________________

Fax:

____________________________________________

Referral Information:
_______________________________________________, from Norton Community Medical Associates
Mt. Washington location has referred the following patient to you for a dilated retinal examination for
evaluation of diabetic retinopathy:
Patient Name: ________________________________________

DOB: _________________________

Insurance: ________________________ Date/time of scheduled exam: ___________________________

EYE EXAM REPORT:

Please FAX this form to the referring Primary Care Provider at ________________________ upon
completion of the patient visit. Please include your treatment plan.
Retinal Examination Findings:
No diabetic retinopathy
Retinal abnormalities detected as follows:
Non-proliferative changes noted in:
Right (Grade)

N/A

Mild

Moderate

Clinically significant diabetic macular edema?
Left (Grade)

N/A

Mild

Severe
Yes

Moderate

Clinically significant diabetic macular edema?

No
Severe

Yes

No

Proliferative changes noted in:
Right (Grade)

N/A

Active

Regressed/Stable

Left (Grade)

N/A

Active

Regressed/Stable

Other: __________________________________________________________________________
Recommended follow-up:

6 months

12 months

Other: ____________________

Additional Comments/Treatment Plan: ________________________________________________
________________________________________________________________________________
Signature: _________________________________

Date: ____________________

Adapted from the Massachusetts Health Promotion Clearinghouse, “Diabetes Eye Exam Referral
and Communication Form,” 2017
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